Is Follicular Lymphoma Non Hodgkins?
Is Follicular Lymphoma Non Hodgkins? Non Hodgkin’s lymphoma encompasses a group of diverse lymphomas, including Follicular Lymphoma. Understanding the distinctions between these types can lead to accurate diagnosis and appropriate treatment. Our aim is to provide clarity and guidance on this topic.
Diagnosing Follicular Lymphoma involves a combination of medical expertise and advanced techniques. Through careful examination and diagnostic tests, healthcare professionals can identify the presence of Follicular Lymphoma and formulate a personalized treatment plan.
Additionally, we will explore the key differences that set Non Hodgkin’s lymphoma apart from Follicular Lymphoma. By understanding these disparities, patients can gain valuable insights into their diagnosis and prognosis.
Get Free Consultation
Our comprehensive overview will also shed light on the diagnostic process for lymphomas as a whole. We will explore the various tests and procedures used to confirm a lymphoma diagnosis, enabling patients to gain a deeper understanding of their medical journey.
Throughout this article, you will find valuable information on treatment options for Follicular Lymphoma, including the latest advances in lymphoma therapy. We will also highlight the availability of cutting-edge treatments offered at Acibadem Healthcare Group.
Furthermore, we will emphasize the significance of raising awareness about lymphomas, including Follicular Lymphoma. By fostering understanding, we can encourage early detection and support those affected by this condition.
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.To assist patients and their loved ones, we will discuss the resources and support systems available to individuals facing a lymphoma diagnosis. Emotional support, survivorship programs, and patient advocacy organizations play vital roles in providing guidance and assistance throughout the lymphoma journey.
In conclusion, we invite you to join us on this informative journey through the world of lymphomas, where we explore Follicular Lymphoma, its connection to Non Hodgkin’s lymphoma, and the essential aspects of diagnosis and treatment. By understanding the interplay between these elements, patients can make informed decisions regarding their healthcare and well-being.
Understanding Non Hodgkin’s Lymphoma
Non Hodgkin’s lymphoma (NHL) is a type of lymphoma that encompasses various subtypes of lymphomas. It is a cancer that begins in the lymphatic system, a key component of the body’s immune system. Lymphomas, including NHL, are characterized by the abnormal growth of lymphocytes, a type of white blood cell.
Types of lymphoma:
- Diffuse Large B-cell Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Marginal Zone Lymphoma (MZL)
- Peripheral T-cell Lymphoma (PTCL)
Each subtype of NHL has unique characteristics and requires tailored treatment approaches. It is crucial for healthcare professionals to accurately diagnose the specific type of lymphoma in order to develop an effective treatment plan.
Lymphoma diagnosis:
Diagnosing NHL involves a combination of medical history assessment, physical examinations, and various diagnostic tests. These tests may include:
- Biopsy: A sample of lymphoid tissue is taken for laboratory analysis to determine if cancer cells are present and identify the specific type of lymphoma.
- Imaging scans: X-rays, CT scans, PET scans, or MRI scans can help visualize the lymph nodes and other areas of the body where lymphoma may be present.
- Blood tests: Blood samples are examined for specific markers and abnormalities associated with lymphoma.
With an accurate diagnosis, healthcare professionals can develop an individualized treatment plan that may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.
The table below provides a comparison of different types of Non Hodgkin’s lymphoma:
| Type of NHL | Cellular Origin | Common Symptoms | Treatment Approaches |
|---|---|---|---|
| Diffuse Large B-cell Lymphoma (DLBCL) | B-cells | Fever, night sweats, weight loss, enlarged lymph nodes | Chemotherapy, immunotherapy, radiation therapy |
| Follicular Lymphoma (FL) | B-cells | No early symptoms, painless swollen lymph nodes, fatigue | Watchful waiting, immunotherapy, targeted therapy |
| Mantle Cell Lymphoma (MCL) | B-cells | Enlarged lymph nodes, fatigue, weight loss, abdominal pain | Chemotherapy, targeted therapy, stem cell transplant |
| Marginal Zone Lymphoma (MZL) | B-cells | Painless swollen lymph nodes, abdominal discomfort, fatigue | Watchful waiting, immunotherapy, radiation therapy |
| Peripheral T-cell Lymphoma (PTCL) | T-cells | Enlarged lymph nodes, fever, night sweats, weight loss | Chemotherapy, targeted therapy, stem cell transplant |
Exploring Follicular Lymphoma
Follicular Lymphoma is a type of Non Hodgkin’s lymphoma that primarily affects the lymphatic system. It is characterized by the abnormal growth of B cells in the lymph nodes, bone marrow, and other organs.
Symptoms of Follicular Lymphoma
The symptoms of Follicular Lymphoma can vary from person to person and may include:
- Enlarged lymph nodes, commonly in the neck, armpits, or groin
- Fatigue and weakness
- Night sweats
- Unintentional weight loss
- Abdominal pain or swelling (in rare cases)
Risk Factors
While the exact cause of Follicular Lymphoma is unknown, there are certain risk factors that may increase the chances of developing this condition, including:
- Age: The risk of Follicular Lymphoma increases with age, with most cases diagnosed in people over 60 years old.
- Sex: Men are slightly more likely to develop Follicular Lymphoma than women.
Importance of Early Detection
Early detection and diagnosis of Follicular Lymphoma are crucial for effective treatment and management. As this type of lymphoma often progresses slowly, it is essential to identify it in its early stages to initiate appropriate interventions.
| Follicular Lymphoma Stage | Description |
|---|---|
| Stage I | The lymphoma is confined to a single lymph node group or a single organ. |
| Stage II | The lymphoma involves two or more lymph node groups on the same side of the diaphragm. |
| Stage III | The lymphoma affects lymph node groups on both sides of the diaphragm or extends to nearby organs. |
| Stage IV | The lymphoma has spread extensively to distant organs, such as the bone marrow or lungs. |
By detecting Follicular Lymphoma in its early stages, healthcare professionals can develop personalized treatment plans to manage the disease and improve patient outcomes.
Differentiating NHL and FL
Non Hodgkin’s lymphoma (NHL) and Follicular Lymphoma (FL) are two distinct types of lymphomas that share some similarities but also have important differences. Understanding these differences is crucial for accurate diagnosis and appropriate treatment.
Cellular Origin and Behavior
NHL refers to a group of lymphomas that originate from the lymphatic system. It encompasses a diverse range of subtypes, each with unique characteristics and behaviors.
On the other hand, FL specifically refers to a subtype of NHL. It arises from abnormal B-lymphocytes, which are a type of white blood cell responsible for producing antibodies to fight infections.
Growth Pattern and Aggressiveness
NHL is known for its wide spectrum of growth patterns and aggressiveness. It can present as slow-growing indolent lymphomas or fast-growing aggressive lymphomas. The behavior of NHL can vary significantly depending on the specific subtype.
FL is generally considered an indolent lymphoma, meaning it has a slow-growing nature. It tends to progress over time, but the rate of progression can be unpredictable. FL is typically characterized by the formation of follicles, which are small collections of abnormal B-lymphocytes.
Clinical Presentation
Both NHL and FL may present with similar symptoms, such as enlarged lymph nodes, fatigue, fever, night sweats, and unintentional weight loss. However, the clinical presentation can vary depending on the subtype and stage of the disease.
Treatment Approaches
Treatment strategies for NHL and FL are tailored based on the specific subtype, stage, and patient’s overall health. The choice of treatment may include watchful waiting, chemotherapy, immunotherapy, radiation therapy, targeted therapy, or stem cell transplantation.
FL, being an indolent lymphoma, often follows a watchful waiting approach for asymptomatic or low tumor burden cases. When treatment becomes necessary, options may include immunotherapy with monoclonal antibodies such as rituximab, chemotherapy, or a combination of both.
Understanding the key differences between NHL and FL is essential for healthcare professionals to provide accurate diagnoses, develop effective treatment plans, and offer personalized care. By recognizing the unique features and behaviors of these lymphomas, patients can receive the most suitable interventions for their specific condition.
Understanding Lymphoma Diagnosis
Diagnosing lymphoma, including Follicular Lymphoma, involves a comprehensive process of tests and procedures to confirm the presence and type of the disease. A correct diagnosis is crucial for determining the most appropriate treatment plan for patients. Here, we will explore the various diagnostic methods utilized in lymphoma diagnosis.
Biopsies
Biopsies are a common procedure used to diagnose lymphoma. During a biopsy, a small sample of tissue is taken from the lymph node or affected area for examination under a microscope. The results of the biopsy can help determine the presence of cancer cells and the specific type of lymphoma.
Imaging Scans
Imaging scans such as CT scans, PET scans, and MRI scans are valuable tools in the diagnosis of lymphoma. These scans provide detailed images of the body’s internal structures, allowing healthcare professionals to assess the size and location of lymph nodes and identify any abnormalities that may indicate lymphoma.
Blood Tests
Blood tests are commonly used to detect lymphoma and assess its progression. These tests may include a complete blood count (CBC), which provides information about the number and types of blood cells, as well as tests to measure specific biomarkers associated with lymphoma.
Other Diagnostic Techniques
In addition to biopsies, imaging scans, and blood tests, other diagnostic techniques such as bone marrow aspiration or biopsy, lumbar puncture, and genetic testing may be utilized in specific cases to further evaluate and confirm a lymphoma diagnosis.
It’s important to note that the diagnostic process may vary for each individual based on their symptoms, medical history, and other factors. A multidisciplinary team of healthcare professionals works together to interpret the results of these tests and provide an accurate diagnosis.
Early and accurate diagnosis is crucial in developing a personalized treatment plan and maximizing chances of successful treatment outcomes. If you suspect any symptoms related to lymphoma, it is essential to consult with a healthcare professional who can guide you through the diagnostic process and provide appropriate care.
Prognosis and Treatment Options
For patients diagnosed with Follicular Lymphoma, understanding the prognosis and exploring the available treatment options is crucial. The outcome and management of this type of lymphoma can vary depending on several factors, including the stage at diagnosis, the patient’s overall health, and the specific characteristics of the lymphoma.
Prognosis and Survival Rates
The prognosis for Follicular Lymphoma has significantly improved over the years, thanks to advancements in research and treatment. However, it is essential to note that Follicular Lymphoma is typically considered an indolent (slow-growing) form of Non Hodgkin’s lymphoma. As a result, the prognosis is generally more favorable compared to aggressive lymphomas.
Several factors can influence the prognosis for patients with Follicular Lymphoma:
- Stage of the disease: The stage at diagnosis plays a significant role in determining the prognosis. Early-stage (localized) Follicular Lymphoma typically has a better prognosis compared to advanced-stage (systemic) disease.
- Grade of the lymphoma: Different grades exist within Follicular Lymphoma, ranging from low-grade to high-grade. The grade can affect the rate of disease progression and response to treatment, which may influence the prognosis.
- Patient factors: The patient’s age, overall health, and response to treatment can also impact the prognosis and survival rates.
It is important to remember that each patient’s prognosis is unique, and prognosis cannot be predicted with absolute certainty. Consultation with a healthcare professional specializing in lymphoma is essential to understand the individual prognosis accurately.
Treatment Options
The treatment approach for Follicular Lymphoma depends on various factors, including the stage of the disease, the extent of lymphoma involvement, and the patient’s overall health and preferences. The primary goal of treatment is to achieve long-term remission, improve quality of life, and manage symptoms.
There are several treatment modalities available for patients with Follicular Lymphoma:
| Treatment Modality | Description |
|---|---|
| Watchful Waiting | In certain cases, especially for individuals with early-stage and asymptomatic disease, a “watch and wait” approach may be recommended. Regular monitoring of the lymphoma is done, and treatment is initiated if the disease progresses or symptoms develop. |
| Chemotherapy | Chemotherapy involves the use of anti-cancer drugs to kill cancer cells. It may be administered alone or in combination with other treatments, such as immunotherapy or targeted therapy. |
| Immunotherapy | Immunotherapy stimulates the body’s immune system to recognize and destroy cancer cells. Monoclonal antibodies, such as rituximab, are commonly used in the treatment of Follicular Lymphoma. |
| Targeted Therapy | Targeted therapy utilizes drugs that specifically target cancer cells, disrupting their growth and survival. Drugs like idelalisib and venetoclax have shown promising results in treating Follicular Lymphoma. |
The choice of treatment depends on various factors, including the individual’s specific condition and the stage of the disease. A multidisciplinary team, including hematologists, oncologists, and other specialists, works closely with patients to develop personalized treatment plans.
It is important to have open and honest discussions with healthcare providers to understand the potential benefits and risks associated with each treatment option. Patients should also discuss any concerns or questions they may have and actively participate in shared decision-making.
Raising Lymphoma Awareness
In order to combat the impact of lymphomas, including Follicular Lymphoma, it is crucial to raise awareness about this group of cancers. Through educational campaigns, support groups, and advocacy organizations, we can contribute to early detection and improved outcomes for patients.
Impact of Awareness Campaigns
Awareness campaigns play a vital role in educating the public about lymphomas and their symptoms. By disseminating accurate information through various channels, such as social media, websites, and community events, these campaigns help individuals understand the importance of seeking medical attention if they experience any concerning symptoms.
Support Groups and Advocacy Organizations
Support groups provide essential emotional support to individuals affected by lymphomas, creating a safe space for sharing experiences and coping strategies. These groups offer invaluable resources, connecting patients, survivors, and their loved ones to a supportive community that understands the challenges they face.
Advocacy organizations contribute significantly to raising lymphoma awareness by advocating for research funding, promoting policy changes, and organizing awareness events. These organizations engage with the public, healthcare professionals, and policymakers to highlight the impact of lymphomas and the urgent need for increased awareness and improved access to treatment.
Through collaborative efforts, awareness campaigns, support groups, and advocacy organizations play a critical role in spreading knowledge about lymphomas and empowering individuals to take proactive steps towards early detection and treatment.
Join the Movement
If you are passionate about making a difference in the lives of lymphoma patients, consider getting involved in awareness initiatives. Join local support groups, volunteer with advocacy organizations, or participate in fundraising events to contribute to the cause and help raise lymphoma awareness in your community.
| Key Benefits of Raising Lymphoma Awareness |
|---|
| Early detection and diagnosis |
| Improved access to specialized care |
| Enhanced emotional support for patients and caregivers |
| Increased research funding and innovation |
| Reduced stigma surrounding lymphoma |
Availability of Treatment at Acibadem Healthcare Group
At Acibadem Healthcare Group, we are committed to providing advanced and comprehensive treatment options for lymphoma patients. Our team of highly skilled oncologists, hematologists, and specialized healthcare professionals are dedicated to delivering exceptional care and personalized treatment plans.
With years of experience and expertise in cancer treatment, Acibadem Healthcare Group is at the forefront of innovative therapies and cutting-edge technologies. Our state-of-the-art facilities are equipped with the latest medical advancements, allowing us to provide the highest quality of care to our patients.
Specialized Services for Lymphoma Treatment
We understand that each patient’s journey is unique. That is why we offer a multidisciplinary approach to lymphoma treatment, combining the expertise of our medical professionals across various disciplines, including hematology, oncology, radiology, and pathology.
Our comprehensive range of treatment options includes:
- Chemotherapy
- Immunotherapy
- Targeted therapy
- Radiation therapy
- Stem cell transplantation
Personalized Care and Support
At Acibadem Healthcare Group, we believe in providing personalized care tailored to the specific needs of each patient. Our compassionate team is dedicated to supporting patients and their families throughout their lymphoma journey.
We prioritize open communication and shared decision-making, ensuring that patients are fully informed and involved in their treatment options.
International Standards of Excellence
As a leading healthcare institution, Acibadem Healthcare Group upholds international standards of excellence in patient care and treatment outcomes. Our commitment to continuous improvement and research has resulted in breakthroughs in cancer treatment.
| Treatment Features | Benefits |
|---|---|
| Advanced diagnostics | Accurate and precise identification of lymphoma subtype |
| Comprehensive treatment plans | Customized approaches for optimal outcomes |
| Minimally invasive procedures | Reduced recovery times and improved quality of life |
| Access to clinical trials | Potential access to innovative therapies and treatments |
When you choose Acibadem Healthcare Group for your lymphoma treatment, you can have confidence in our commitment to clinical excellence and exceptional patient care.
Contact us today to learn more about our specialized services and schedule a consultation with our experienced oncology team.
Promising Research and Advances in Lymphoma Treatment
The field of lymphoma treatment is continuously evolving, with ongoing research efforts focused on improving patient outcomes. Emerging therapies, clinical trials, and innovative approaches are showing promise in enhancing cancer treatment. Here, we will explore some of the latest advancements in lymphoma treatment that are revolutionizing the way we combat this complex disease.
1. Immunotherapy
Immunotherapy has emerged as a groundbreaking approach to cancer treatment, including lymphomas. This innovative technique harnesses the power of the immune system to identify and destroy cancer cells. By stimulating immune responses, immunotherapy has shown remarkable success in treating different types of lymphoma. One particularly promising immunotherapy treatment is CAR-T cell therapy, which involves genetically modifying a patient’s own T cells to better recognize and attack lymphoma cells.
2. Targeted Therapy
Unlike conventional chemotherapy, targeted therapy attacks specific molecules or pathways involved in the growth and survival of cancer cells. This precision-oriented approach minimizes damage to healthy cells and reduces side effects. In the field of lymphoma treatment, targeted therapies have proven effective in managing certain types of lymphoma, leading to improved outcomes and prolonged survival for patients.
3. Precision Medicine
Advances in genomic profiling have paved the way for precision medicine in lymphoma treatment. By analyzing the genetic alterations specific to an individual’s lymphoma cells, healthcare professionals can tailor treatment plans to target these specific mutations. This personalized approach ensures that patients receive the most effective therapies, leading to better response rates and increased survival rates.
4. Combination Therapies
Combination therapies, which involve using multiple drugs or treatment modalities simultaneously, are being explored to maximize treatment efficacy in lymphomas. By leveraging the synergistic effects of different treatments, combination therapies have demonstrated improved response rates and long-term outcomes. Additionally, these approaches are helping to overcome drug resistance and enhance the overall effectiveness of cancer treatment.
5. Clinical Trials and Novel Approaches
Clinical trials play a crucial role in testing new treatments and evaluating their safety and effectiveness. Through participation in clinical trials, patients have access to experimental therapies and cutting-edge treatment approaches that are not yet widely available. These trials are advancing the field of lymphoma treatment by exploring innovative treatment combinations, immunotherapies, and novel targeted therapies.
As ongoing research continues to unravel the complexities of lymphoma, advancements in cancer treatment are offering hope to patients around the world. The development of these new and effective therapies, combined with personalized approaches and precision medicine, is revolutionizing the fight against lymphoma and improving outcomes for those diagnosed with this challenging disease.
Support and Resources for Lymphoma Patients
Being diagnosed with lymphoma can be overwhelming, but you don’t have to face it alone. There are numerous support systems and resources available to help lymphoma patients and their loved ones navigate their journey. From emotional support to survivorship programs and patient advocacy organizations, these resources can provide valuable assistance throughout the cancer treatment process.
Emotional Support
Receiving a lymphoma diagnosis can trigger a range of emotions, including fear, anxiety, and uncertainty. It is crucial to acknowledge and address these feelings. Many hospitals and cancer centers offer counseling services, support groups, and therapy programs specifically designed for cancer patients and their families. These resources can provide emotional support, guidance, and coping strategies to help you navigate the challenges that come with lymphoma treatment.
Survivorship Programs
After completing cancer treatment, survivors often require ongoing care and support to maintain their well-being. Survivorship programs cater to the unique needs of cancer survivors and focus on issues such as surveillance for recurrence, managing late effects of treatment, and strategies for maintaining a healthy lifestyle. These programs empower lymphoma survivors to take charge of their long-term health and provide a sense of community through shared experiences.
Patient Advocacy Organizations
There are various patient advocacy organizations dedicated to supporting individuals affected by lymphoma. These organizations offer a wealth of information on treatment options, clinical trials, research advancements, and financial assistance programs. They also advocate on behalf of patients, working to improve access to quality care and raise awareness about lymphoma. Connecting with these organizations can help you stay informed, connected, and empowered throughout your cancer journey.
Remember, seeking support cannot only provide practical assistance but also help improve your overall well-being. Utilizing available resources can enhance your understanding of lymphoma treatment options, alleviate emotional burdens, and ensure that you and your loved ones receive the comprehensive care you deserve.
Conclusion
In conclusion, understanding the connection between Follicular Lymphoma (FL) and Non Hodgkin’s lymphoma (NHL) is crucial for patients and healthcare professionals alike. Throughout this article, we have explored the differences between these two types of lymphomas and emphasized the importance of early detection for FL.
By recognizing the distinct characteristics and behaviors of FL compared to NHL, patients can receive appropriate diagnosis and treatment plans tailored to their specific condition. The diagnostic process for lymphoma involves a range of tests and procedures, including biopsies, imaging scans, and blood tests.
If you or a loved one have been diagnosed with lymphoma, we urge you to seek medical advice and guidance. By working closely with healthcare professionals, you can gain personalized information about your diagnosis and available treatment options. Remember, early detection and prompt intervention can greatly improve outcomes for patients with FL and other types of lymphoma.
FAQ
Is Follicular Lymphoma a type of Non Hodgkin's lymphoma?
Yes, Follicular Lymphoma is a type of Non Hodgkin's lymphoma.
What is the difference between NHL and FL?
Non Hodgkin's lymphoma (NHL) is a broad category that includes various types of lymphomas, including Follicular Lymphoma (FL). FL is a specific subtype of NHL characterized by abnormal growth of certain white blood cells.
How is Follicular Lymphoma diagnosed?
Follicular Lymphoma is typically diagnosed through a combination of medical history evaluation, physical examination, blood tests, imaging scans (such as CT or PET scans), and biopsy of the affected lymph nodes or bone marrow.
What are the symptoms and risk factors of Follicular Lymphoma?
Symptoms of Follicular Lymphoma may include swollen lymph nodes, fatigue, unexplained weight loss, night sweats, and fever. Risk factors for developing Follicular Lymphoma include older age, family history of lymphoma, and certain genetic mutations.
How does the prognosis of Follicular Lymphoma vary?
The prognosis of Follicular Lymphoma varies from person to person and depends on various factors, including the stage of the cancer, the overall health of the patient, and the response to treatment. While Follicular Lymphoma is generally considered incurable, many patients have a long-term, manageable disease course.
What are the treatment options for Follicular Lymphoma?
Treatment options for Follicular Lymphoma may include watchful waiting, radiation therapy, chemotherapy, immunotherapy, targeted therapy, and stem cell transplantation. The choice of treatment depends on the stage and extent of the disease, as well as the individual patient's condition and preferences.
How can raising lymphoma awareness help?
Raising awareness about lymphomas, including Follicular Lymphoma, can help with early detection, improved understanding among healthcare professionals, and increased support for research and funding. It also promotes public education and empowers patients to seek timely medical attention.
Are advanced treatment options available at Acibadem Healthcare Group?
Yes, Acibadem Healthcare Group offers advanced treatment options for lymphoma patients. They provide specialized services and expertise in diagnosing and treating lymphomas, ensuring personalized care and comprehensive support.
What are the latest research advancements in lymphoma treatment?
Ongoing research in lymphoma treatment has led to promising advancements, such as targeted therapies, immunotherapies, and novel combination treatment approaches. Clinical trials and scientific studies continue to explore new strategies to improve patient outcomes and quality of life.
What support and resources are available for lymphoma patients?
Lymphoma patients and their families can access various support systems and resources, including emotional support networks, survivorship programs, educational materials, and patient advocacy organizations. These resources help individuals navigate their lymphoma journey and provide valuable information and assistance.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now!*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of Acıbadem Health Group.